New president of Europharm
This article was originally published in Scrip
Alexander Burstein has been elected president of Europharm, the European Association for Small and Medium-Sized Pharmaceutical Companies. Mr Burstein, who is also director of development affairs at the Austrian company Sanova Pharma (which is owned by the German wholesaler, Celesio), will hold the position for two years. Europharm represents 200 SMEs from across Europe and has an office in Brussels.
You may also be interested in...
The European Commission has granted a marketing authorization for UCB and Amgen’s bone-building MAb, romosozumab, and first launches are expected in the first half of 2020; patient groups suggest that the prevention and treatment of fragility fractures has not attracted the attention it deserves.
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
A PFS benefit and favorable tolerability profile associated with AstraZeneca’s BTK inhibitor acalabrutinib used first-line in CLL, when given alone or combined with obinutuzumab, may serve it well against entrenched competitors and BTK inhibitors in clinical development.